Decapod Iridescent Virus 1 (DIV1) threatens global aquaculture, particularly the economically important Macrobrachium rosenbergii, causing massive mortalities and substantial economic losses. Conventional lethal sampling (e.g., gills or hepatopancreas) hinders longitudinal monitoring, damages valuable broodstock, and limits disease-resistance selection, creating an urgent need for a non-lethal, sensitive method to detect low DIV1 viral loads.
This 6-month innovative study developed and validated a minimally invasive fourth pereiopod biopsy for DIV1 detection (Fig. 1). We evaluated three qPCR targets (MCP, ATPase, HP11L), optimized the biopsy procedure, assessed post-biopsy survival and appendage regeneration, and validated 123 DIV1-exposed prawns using gold-standard assays (histopathology, ISDL, TEM). The MCP gene was identified as optimal, and the fourth pereiopod biopsy exhibited superior viral abundance and stability (Fig. 2), with a 98% 30-day post-biopsy survival rate and full appendage regeneration within 4 weeks. This method detected low viral loads with 100% concordance with lethal gold standards, confirmed by characteristic lesions, ISDL positivity, and TEM-visualized.
This novel non-lethal method enables longitudinal monitoring, broodstock preservation, and genetic selection, providing new insights to enhance global aquaculture biosecurity and sustainability. Its broad relevance and clarity make it accessible to the wider aquaculture community, with the included figures further enhancing its utility.